Cylert

2023年5月23日 — On September 2, 2021, Abbott requested that FDA withdraw approval of CYLERT (pemoline) tablets and CYLERT (pemoline) chewable tablets, NDAs ...

Cylert (pemoline) is a central nervous system stimulant used to treat attention deficit hyperactivity disorder (ADHD). The brand name Cylert is no longer ...

2023年12月13日 — Pemoline increases attention and decreases restlessness in children who are overactive, cannot concentrate for very long or are easily ...

2023年10月13日 — Cylert is a central nervous system stimulant used to treat attention deficit hyperactivity disorder (ADHD). The brand name Cylert is no ...

CYLERT (pemoline) is indicated in Attention Deficit Hyperactivity Disorder (ADHD). Because of its association with life threatening hepatic failure, CYLERT ...

由 DS Pratt 著作 · 1990 · 被引用 41 次 — Pemoline (Cylert) is an agent used to treat attention deficit disorders and other behavioral syndromes. There have, however, been three published reports of ...

Pemoline, sold under the brand name Cylert among others, is a stimulant medication which has been used in the treatment of attention-deficit hyperactivity ...

Pemoline (Cylert) is a non-MPH and nonamphetamine stimulant (Table 1) that is prescribed once a day to achieve beneficial steady-state levels; occasionally, an ...

Cylert is a central nervous system stimulant indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD). This product is considered second ...

Cylert increases attention and reduces restlessness in children who are overactive, unable to concentrate for too long or are easily distracted, and emotionally ...